Afya Limited (AFYA) Balance Sheet

The steady increase in total assets suggests that management continues to deploy capital into the business, likely through both organic campus development and strategic acquisitions. Investors should monitor whether this asset growth continues to generate commensurate returns on invested capital as the Brazilian medical education market approaches a more saturated phase.

The company's ability to maintain a consistent D/E ratio despite significant asset expansion suggests that internal cash generation is effectively offsetting the need for excessive external financing. This leverage profile appears sustainable, provided that the core undergraduate medical segment continues to deliver the predictable cash flows necessary for debt servicing.

The high concentration of goodwill warrants close scrutiny, as it implies that a substantial portion of the company's book value is tied to the premium paid for past acquisitions. If regulatory shifts or competitive pressures diminish the value of these acquired assets, the company could face future impairment risks that would negatively impact its equity position.

The strengthening cash position, coupled with a current ratio of 1.78 as of 2026Q1, suggests that the company is well-positioned to meet its short-term obligations without relying on external credit markets. This liquidity cushion is particularly important given the inherent volatility in working capital cycles associated with tuition collection and government-related receivables.

The steady growth in retained earnings indicates that the company is successfully converting its operational success into long-term shareholder value. This trend suggests a healthy balance sheet trajectory, as the company relies more on internally generated capital than on equity dilution to finance its ongoing expansion and strategic initiatives.